Phenylbutyrate for Monogenetic Developmental and Epileptic Encephalopathy

Clinical trial NCT04937062 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04937062
Sponsor: Weill Medical College of Cornell University
Status: ACTIVE_NOT_RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

STXBP1 Encephalopathy With Epilepsy, SLC6A1 Neurodevelopmental Disorder Developmental and Epileptic Encephalopathy

Start date: 2021-03-01
Primary completion: 2026-12-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.